BRKR
Bruker Corporation (Nasdaq: BRKR) announced it will report second quarter 2026 financial results before...
Article Summary
HOLD- Bruker Corporation (Nasdaq: BRKR) announced it will report second quarter 2026 financial results before market opening on Tuesday, August 4, 2026, with a conference call and webcast at 9:00 a.m.
- Eastern Daylight Time to discuss results and current business trends.
- Bruker is enabling investors to pre-register for the earnings conference call so that they can expedite entry into the call and avoid the need to wait for a live operator.
- Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as clinical microbiology and molecular diagnostics.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts.
See Plans
Growth Stock Scoring Breakdown
| METRIC | VALUE | WEIGHT | ANALYSIS |
|---|---|---|---|
| Sales Growth TTM ? | 0.4% | 25% | 20.0 ptsMinimal (0.4%) - Very weak |
| EPS Growth Next 5Y ? | 15.8% | 25% | 50.0 ptsMeets Minimum (15.8%) - Passes screener |
| Target Price Upside ? | 1.2% | 20% | 10.0 ptsNear/At Target (1.2%) - Target: $59.75 vs Current: $60.45 |
| Gross Margin % ? | 46.3% | 15% | 60.0 ptsSolid (46.3%) - Decent margins |
| Drawdown from 52-Wk High ? | -6.3% | 15% | 20.0 ptsBarely a Dip (-6.3%) - Near recent highs |
Disclaimer: This rating is for informational purposes only and is not financial advice.
All data sourced from Finviz.
Always conduct your own research and consult with a financial advisor before making investment decisions.
Past performance does not guarantee future results.
About BRKR
- Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
- It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
- The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions.
- It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment.
- In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation.
- Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.